Search
Methylene blue
go.drugbank.com/drugs/DB09241ApprovedInvestigationalMethylthioninium chloride (INN, or methylene blue, proposed trade name Rember) is an investigational drug being developed by the University of Aberdeen and TauRx Therapeutics that has been shown in early … Methylene blue is an oxidation-reduction agent. The intravenous form of methylene blue is approved by the FDA for the treatment of pediatric and adult patients with acquired methemoglobinemia.
Mixtures: Uro-L, UR N-C Urinary AntisepticCategories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Tests for Gastric SecretionCetrorelix
go.drugbank.com/drugs/DB00050ApprovedInvestigationalWhen undergoing hormone treatment sometimes premature ovulation can occur, leading to eggs that are not ready for fertilization to be released. … GnRH controls another hormone that is called luteinizing hormone (LH), which is the hormone that starts ovulation during the menstrual cycle.
Products: Cetrotide 0.25 mg powder and solvent for solution for injection, Asporelix 0.25 (Cetrorelix 0.25mg Powder and Solvent for Solution for Injection)Fomivirsen
go.drugbank.com/drugs/DB06759ApprovedWithdrawnThe drug was withdrawn by the FDA because while there was a high unmet need for drugs to treat CMV when the drug was initially discovered and developed due to the CMV arising in people with AIDS, the development … As a complementary nucleotide to the messenger RNA of the major immediate-early region proteins of human cytomegalovirus, it disrupts the replication of the virus through an antisense mechanism [L1428]
Categories: Compounds used in a research, industrial, or household settingMaraviroc
go.drugbank.com/drugs/DB04835ApprovedInvestigationalIt was approved for use by the FDA in August, 2007. … Maraviroc (brand-named Selzentry, or Celsentri outside the U.S.) is a chemokine receptor antagonist drug developed by the drug company Pfizer that is designed to act against HIV by interfering with the
Categories: Antivirals for Systemic Use, Antiinfectives for Systemic UseLoxoprofen
go.drugbank.com/drugs/DB09212ApprovedInvestigationalA transdermal preparation was approved for use in Japan in January 2006. … Loxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug.
Categories: Topical Products for Joint and Muscular Pain, Antiinflammatory Preparations, Non-Steroids for Topical UseAdenosine phosphate
go.drugbank.com/drugs/DB00131ApprovedInvestigationalNutraceuticalWithdrawnAdenosine phosphate was withdrawn by the FDA since it was considered neither safe nor effective for its intended uses as a vasodilator and an anti-inflammatory.[L43937] … Adenosine phosphate, or adenylic acid, is an adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.
International brands: My-B-DenPiperidione
go.drugbank.com/drugs/DB13224ExperimentalPiperidione was cough medicine marketed by Roche under the trade name Sedulon.
Primary Ovarian Insufficiency
go.drugbank.com/conditions/DBCOND0000990Synonyms: Premature Ovarian Failure (POF), POF - Premature ovarian failureSerplulimab
go.drugbank.com/drugs/DB17451ApprovedInvestigationalIt was first approved in China - where it is indicated for a number of different cancers[L52963] - and has since been approved in several southeast Asian countries. … Most recently, it was approved in the EU in February 2025 for the treatment of extensive-stage small cell lung cancer.[L52968,L52953]
Categories: PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitorsMethimazole
go.drugbank.com/drugs/DB00763ApprovedInvestigationalpro-drug [carbimazole], which is an antithyroid medication used in the United Kingdom and parts of the former British Commonwealth. … [A184559,A184733,A184694] It was first introduced as an antithyroid agent in 1949[A184502] and is now commonly used in the management of hyperthyroidism, particularly in those for whom more aggressive